Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement

@article{KraeberBodr2000TreatmentOB,
  title={Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement},
  author={Françoise Kraeber-Bod{\'e}r{\'e} and Lo{\"i}c Campion and Caroline Rousseau and Sylvain Bourdin and J. Chatal and Isabelle Resche},
  journal={European Journal of Nuclear Medicine},
  year={2000},
  volume={27},
  pages={1487-1493}
}
This retrospective study evaluated the toxicity and efficacy of strontium-89 chloride (Metastron, Amersham) in 94 patients with painful bone metastases of prostate cancer (117 injections of 150 MBq) and compared the efficacy of treatment in patients with moderate and extensive bone involvement. The predictive value of flare response with regard to analgesic… CONTINUE READING